WST
West Pharmaceutical Services Inc
NYSE: WST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$297.59
+0.76% today
Updated 2026-04-30
Market cap
$20.64B
P/E ratio
39.05
P/S ratio
6.41x
EPS (TTM)
$7.48
Dividend yield
0.28%
52W range
$202 – $322
Volume
0.9M
WallStSmart proprietary scores
67
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+7.3
Quality
B+8.0
Profitability
A2.7
Valuation
F5/9
Piotroski F-Score
Moderate
4.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$349.85
+17.56%
12-Month target
$203.74
-31.54%
Intrinsic (DCF)
$184.38
Margin of safety
-33.51%
2 Strong Buy10 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Altman Z 4.91 — safe zone
+ Free cash flow $47.20M — positive
+ Revenue growth 21.00% QoQ
Risks
- 33.51% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.89B | $2.95B | $2.89B | $3.07B | $3.22B |
| Net income | $585.90M | $593.40M | $492.70M | $493.70M | $138.80M |
| EPS | — | — | — | — | $7.48 |
| Free cash flow | $439.40M | $414.50M | $276.40M | $468.90M | $47.20M |
| Profit margin | 20.30% | 20.11% | 17.03% | 16.06% | 16.90% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | HAUGEN, JANET BRUTSCHEA | Buy | 52 | $250.64 |
| 2026-03-01 | WINTERS, CHAD | Buy | 808 | — |
| 2026-03-01 | WINTERS, CHAD | Buy | 340 | — |
Peer comparison
Smart narrative
West Pharmaceutical Services Inc trades at $297.59. representing a P/E of 39.05x trailing earnings. Our Smart Value Score of 67/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 4.91, it sits in the safe zone. TTM revenue stands at $3.22B. with profit margins at 16.90%. Our DCF model estimates intrinsic value at $184.38.
Frequently asked questions
What is West Pharmaceutical Services Inc's stock price?
West Pharmaceutical Services Inc (WST) trades at $297.59.
Is West Pharmaceutical Services Inc overvalued?
Smart Value Score 67/100 (Grade B, Buy). DCF value $184.38.
What is the price target of West Pharmaceutical Services Inc (WST)?
The analyst target price is $349.85, representing +17.6% upside from the current price of $297.59.
What is the intrinsic value of West Pharmaceutical Services Inc (WST)?
Based on our DCF model, intrinsic value is $184.38, a -33.5% margin of safety versus $297.59.
What is West Pharmaceutical Services Inc's revenue?
TTM revenue is $3.22B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
4.91 — safe zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio6.41x
ROE19.10%
Beta1.15
50D MA$254.85
200D MA$258.14
Shares out0.07B
Float0.07B
Short ratio—
Avg volume0.9M
Performance
1 week-3.53%
1 month+16.86%
3 months+27.80%
YTD+7.35%
1 year—
3 years—
5 years—